(Q37050151)

17 August 2017

1 reference

title

What factors contribute to the inadequate control of elevated blood pressure? (English)

1 reference

17 August 2017

William J Elliott

1

1 reference

17 August 2017

1 January 2008

1 reference

Journal of Clinical Hypertension

17 August 2017

1 reference

17 August 2017

10

1 reference

17 August 2017

1 Suppl 1

1 reference

17 August 2017

20-26

1 reference

Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Reasons for not intensifying antihypertensive treatment (RIAT): a primary care antihypertensive intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

The effect of a losartan-based treatment regimen on isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Hypertension treatment and control in five European countries, Canada, and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Long-term adherence with cardiovascular drug regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Rate and determinants of 10-year persistence with antihypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

A population-based European cohort study of persistence in newly diagnosed hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Antihypertensive medication adherence in the Department of Veterans Affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Low-dose combination therapy: an important first-line treatment in the management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Combination drug treatment of hypertension: have we come full circle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Association of refill adherence and health care use among adults with hypertension in an urban health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Nitric oxide in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

More medications, fewer pills: combination medications for the treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Fixed-dose combinations improve medication compliance: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Is fixed combination therapy appropriate for initial hypertension treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2007.08028.X

10.1111/J.1524-6175.2007.08028.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18174780